ClearBridge Investments’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.5M Sell
3,716,181
-864,835
-19% -$20M 0.08% 236
2026
Q1
$110M Sell
4,581,016
-1,091,629
-19% -$26.7M 0.1% 194
2025
Q4
$128M Sell
5,672,645
-224,953
-4% -$4.9M 0.1% 196
2025
Q3
$119M Buy
5,897,598
+500,164
+9% +$8.38M 0.09% 213
2025
Q2
$77.1M Buy
+5,397,434
New +$63.1M 0.06% 259

Other funds holding ELAN

ClearBridge Investments's ELAN Position: Q2 2026 in Review

ClearBridge Investments reduced its Elanco Animal Health (ELAN) stake by 19% in Q2 2026, selling an estimated $20M and leaving 3,716,181 shares worth $91.5M. The position accounts for 0.08% of the portfolio, ranked #236.

ClearBridge Investments first reported a position in ELAN in Q2 2025 and has held it in 5 quarters since. The position peaked at $128M in Q4 2025. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • ClearBridge Investments held 3,716,181 shares of Elanco Animal Health worth $91.5M as of Q2 2026.
  • ClearBridge Investments sold 864,835 Elanco Animal Health shares in Q2 2026, an estimated $20M.
  • Elanco Animal Health made up 0.08% of ClearBridge Investments's portfolio in Q2 2026, its #236 holding.
  • ClearBridge Investments first reported a position in Elanco Animal Health in Q2 2025 and has held it in 5 quarters since.
  • ClearBridge Investments's Elanco Animal Health position peaked at $128M in Q4 2025.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.